Search research articles
Contact Us
Filters
Showing results (1291-1300 of 1,331) with videos related to
Page
of 134
Sort By:
The New England Journal of Medicine
|
January 18, 2023
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years
Patricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.
Nature Communications
|
December 5, 2025
Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines
Wei Chen, Kristin R Tompkins, Ian W Windsor, et al.
Journal of the Pediatric Infectious Diseases Society
|
June 11, 2024
Bivalent Omicron BA.4/BA.5 BNT162b2 Vaccine in 6-Month- to <12-Year-Olds
Lawrence D Sher, Justice K Boakye-Appiah, Sungeen Hill, et al.
Nature Medicine
|
September 14, 2021
Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial
Martina Oneko, Laura C Steinhardt, Reuben Yego, et al.
The New England Journal of Medicine
|
September 15, 2021
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, et al.
The New England Journal of Medicine
|
April 5, 2023
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults
Edward E Walsh, Gonzalo Pérez Marc, Agnieszka M Zareba, et al.
Cell Reports
|
August 24, 2025
A capsular polysaccharide from a healthy human microbiota member activates a Lag-3-NK cell axis to restrain colon cancer and augment immunotherapy
Allison M Weis, Kaylyn M Bauer, William W Tang, et al.
Toxicologic Pathology
|
February 7, 2022
Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models
Shambhunath Choudhary, Isis Kanevsky, Soner Yildiz, et al.
The New England Journal of Medicine
|
March 23, 2022
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
Edson D Moreira, Nicholas Kitchin, Xia Xu, et al.
Clinical Colorectal Cancer
|
May 3, 2021
Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study
Yannick Eisele, Patrick M Mallea, Biljana Gigic, et al.
Page
of 134
Search research articles
Search
Showing results (1291-1300 of 1,331) with videos related to
Sort By:
Page
of 134
The New England Journal of Medicine
|
January 18, 2023
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years
Patricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.
Nature Communications
|
December 5, 2025
Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines
Wei Chen, Kristin R Tompkins, Ian W Windsor, et al.
Journal of the Pediatric Infectious Diseases Society
|
June 11, 2024
Bivalent Omicron BA.4/BA.5 BNT162b2 Vaccine in 6-Month- to <12-Year-Olds
Lawrence D Sher, Justice K Boakye-Appiah, Sungeen Hill, et al.
Nature Medicine
|
September 14, 2021
Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial
Martina Oneko, Laura C Steinhardt, Reuben Yego, et al.
The New England Journal of Medicine
|
September 15, 2021
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, et al.
The New England Journal of Medicine
|
April 5, 2023
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults
Edward E Walsh, Gonzalo Pérez Marc, Agnieszka M Zareba, et al.
Cell Reports
|
August 24, 2025
A capsular polysaccharide from a healthy human microbiota member activates a Lag-3-NK cell axis to restrain colon cancer and augment immunotherapy
Allison M Weis, Kaylyn M Bauer, William W Tang, et al.
Toxicologic Pathology
|
February 7, 2022
Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models
Shambhunath Choudhary, Isis Kanevsky, Soner Yildiz, et al.
The New England Journal of Medicine
|
March 23, 2022
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
Edson D Moreira, Nicholas Kitchin, Xia Xu, et al.
Clinical Colorectal Cancer
|
May 3, 2021
Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study
Yannick Eisele, Patrick M Mallea, Biljana Gigic, et al.
Page
of 134